[quote=“rgcainmd, post:13, topic:57893, full:true”]
The old, cynical, and bitter part of me (which grew three sizes the day my daughter was diagnosed with T1D) believes that the primary incentive to slow the pricing increase is to look good on Twitter. And sliding in a little extra free advertising for Tresiba isn’t hurting, either. They don’t give a hot damn about us. Whether we little people will see any benefit after the PBMs take their grubby, greedy little fingers off the vials and pens of insulin that we actually already paid for with our insurance premiums and continue to pay for with our astronomical co-payments is yet to be seen. I’m not holding my breath. They think we are complete idiots: “Oh how nice of them not to increase their costs as much as the other Big Boys. They’re doing this because they, too, are outraged at how much we pay every month to stay alive and they know it will make the other manufacturers not increase their prices as much either, and pretty soon every pharmaceutical company will see the error of their ways and will care about making the world a less expensive place for people who need medications, and we will all live happily ever after. The End.” NOT.
A little more vitriol for good measure. I’m probably preaching to the choir, but here goes. I honestly believe that they developed Tresiba (and put some real effort into actually making this better than the other long-acting insulins on the market) because they finally read the writing on the wall and realized they were complete doofs for not diversifying earlier in the game like the other Big Boys did (the ones who produce meds for diseases other than D.) Yeah, I believe (or I’d like to think) that the scientists who worked long, hard hours to develop Tresiba were driven by a genuine desire to benefit mankind. But that’s about the extent of it as far as my shriveled black heart is concerned. I realize that R & D costs far more than most people will ever realize. And I know that the Big Boys are no different from any one of us in that we all want to make a buck.
But this? Thank you so very much for not increasing your prices more than you think we think you probably could. This is not an act of altruism. It is a CYA move; their well-paid market analysts likely said “If you don’t do this, you stand to lose more than you will gain.”
[/quote]Rose, your libels against various peoples and companies in the health care industry really bother me.
Physicians are not all greedy jerks playing golf most of the day. Lawyers are not all a bunch of shysters. And on and on. Indeed, for the most part, doctors and lawyers are good people, trying to help those they serve professionally.
Why you think its any different at Sanofi, Lilly, Novo Nordisk, etc. makes me sad. A lot of people here share those derogatory views.
And they’re wrong, and unfair.
Are there people in the pharma industry that are greedy, self-centered, narscissitic jerks who don’t give a damn about the patients, but see us as you describe? Of course. Guess what? They’re doctors like that too.
Are most people in pharma like that? Most doctors? No. Of course not.
We may not agree with every priority and aspect that goes into a decision to pursue a particular treatment possibility, and of course making money (or seen differently, a living) is usually one of them. However, in my travels around the medical device and pharma industries – light travel, I admit, but not completely without getting to know some people – the desire to help people and possibly even cure them is prominent. This applies to executives down through managers to grunts.
I have an Omnipod because John Brooks III, the founder of Insulet, saw a better way for his T1D son. It was never about greed. The story’s very similar for Dexcom too.
Note that both Dexcom and Insulet, companies we are both customers of and love their product, continue to lose money. Neither has ever made a profit. Yet, many here point the finger of greed at these companies, especially Dexcom, for their prices. What greed: The compulsion to lose MORE money?